loading
NanoViricides Inc stock is traded at $1.44, with a volume of 109.54K. It is up +5.11% in the last 24 hours and down -15.29% over the past month. NanoViricides, Inc., a nano-biopharmaceutical company, discovers, develops, and commercializes therapeutics for the treatment of viral infections. The company is developing anti-influenza drug candidates at pre-clinical and advanced pre-clinical stage, which include two FluCide drugs, such as NV-INF-2, an oral anti-influenza drug and NV-INF-1, an injectable anti-influenza drug for H7N9, Bird Flu H5N1, and other Highly Pathogenic Influenzas; and HIVCide, an anti-human immunodeficiency virus (HIV) drug candidate that could provide functional cure for HIV/AIDS. It is also developing HerpeCide, a skin cream or gel formulation for the treatment of oral and genital herpes virus infections; and eye drops against viral infections of the external eye, as well as involved in the other research programs against Rabies virus, Ebola, and Marburg viruses. NanoViricides, Inc. was founded in 2005 and is based in Shelton, Connecticut.
See More
Previous Close:
$1.37
Open:
$1.38
24h Volume:
109.54K
Relative Volume:
0.44
Market Cap:
$23.14M
Revenue:
-
Net Income/Loss:
$-8.29M
P/E Ratio:
-2.0571
EPS:
-0.7
Net Cash Flow:
$-6.47M
1W Performance:
-4.00%
1M Performance:
-15.29%
6M Performance:
-4.00%
1Y Performance:
-21.74%
1-Day Range:
Value
$1.37
$1.45
1-Week Range:
Value
$1.3401
$1.57
52-Week Range:
Value
$0.94
$2.07

NanoViricides Inc Stock (NNVC) Company Profile

Name
Name
NanoViricides Inc
Name
Phone
203-937-6137
Name
Address
1 Controls Drive, Shelton, CT
Name
Employee
7
Name
Twitter
@nnvcnyse
Name
Next Earnings Date
2025-05-20
Name
Latest SEC Filings
Name
NNVC's Discussions on Twitter

Compare NNVC with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
NNVC
NanoViricides Inc
1.44 24.59M 0 -8.29M -6.47M -0.70
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
395.12 99.96B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
589.48 60.83B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
454.38 59.89B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
660.00 40.47B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
313.67 37.96B 3.81B -644.79M -669.77M -6.24

NanoViricides Inc Stock (NNVC) Upgrades & Downgrades

Date Action Analyst Rating Change
Feb-11-15 Initiated Midtown Partners Strong Buy

NanoViricides Inc Stock (NNVC) Latest News

pulisher
Aug 20, 2025

Heatmap analysis for NanoViricides Inc. and competitorsJuly 2025 Outlook & Scalable Portfolio Growth Methods - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Risk adjusted return profile for NanoViricides Inc. analyzedEarnings Growth Report & Verified Technical Signals - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Will NanoViricides Inc. rebound enough to break evenRecession Risk & Long-Term Capital Growth Strategies - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Technical Bounce Expected in NanoViricides Inc. Next Week2025 Major Catalysts & Reliable Trade Execution Plans - mustnews.co.kr

Aug 20, 2025
pulisher
Aug 20, 2025

Historical volatility pattern of NanoViricides Inc. visualized2025 Key Highlights & Community Verified Trade Alerts - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Analyzing net buyer seller activity in NanoViricides Inc.Portfolio Profit Report & Safe Capital Growth Tips - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Market reaction to NanoViricides Inc.’s recent newsTrade Volume Report & Real-Time Stock Price Movement Reports - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

NanoViricides Inc. stock retracement – recovery analysisJuly 2025 Market Mood & Fast Exit and Entry Strategy Plans - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Signal strength of NanoViricides Inc. stock in tech scannersMarket Activity Report & Entry Point Confirmation Signals - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

NanoViricides Inc. recovery potential after sell offJuly 2025 Opening Moves & Community Verified Watchlist Alerts - Newser

Aug 20, 2025
pulisher
Aug 19, 2025

Why NanoViricides Inc. stock attracts strong analyst attentionWeekly Stock Recap & Real-Time Volume Analysis - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Real time social sentiment graph for NanoViricides Inc.July 2025 Retail & Consistent Profit Trade Alerts - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Small Cap Stocks: 374Water, Canagold Resources, Ocean Power, Giyani Metals, NanoViricides, Viking Therapeutics, HIVE Digital Technologies, American Resources Corp, Ocean Power Technologies, 374Water Inc, Canagold Resources Ltd. - AInvest

Aug 19, 2025
pulisher
Aug 19, 2025

NanoViricides' NV-387 May Reduce Cancer Resurgence Risk Linked to Viral Infections - AInvest

Aug 19, 2025
pulisher
Aug 19, 2025

Using Python tools to backtest NanoViricides Inc. strategiesTrade Entry Summary & Weekly Breakout Stock Alerts - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Published on: 2025-08-19 13:51:24 - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Nanoviricides, Inc. shares rise 1.31% premarket after announcing NV-387 antiviral drug's potential for treating multiple viral infections. - AInvest

Aug 19, 2025
pulisher
Aug 19, 2025

Sentiment analysis tools applied to NanoViricides Inc.July 2025 Selloffs & Risk Managed Investment Signals - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Multi Factor Analysis Ranks NanoViricides Inc. as Strong BuyPortfolio Gains Report & Long-Term Safe Investment Plans - theviewers.co.kr

Aug 19, 2025
pulisher
Aug 19, 2025

What MACD and RSI say about NanoViricides Inc.2025 Geopolitical Influence & High Accuracy Investment Signals - Newser

Aug 19, 2025
pulisher
Aug 18, 2025

What makes NanoViricides Inc. stock price move sharplyRisk Management & Long Hold Capital Preservation Tips - Newser

Aug 18, 2025
pulisher
Aug 18, 2025

NanoViricides says antiviral NV-387 may reduce cancer resurgence risk tied to viral infections - Proactive financial news

Aug 18, 2025
pulisher
Aug 18, 2025

A Drug that Could Reduce Metastatic Cancer Resurgence due to Its Anti-Inflammatory Effects in Viral Infections is in Clinical Trials - Lelezard

Aug 18, 2025
pulisher
Aug 18, 2025

Breakthrough Anti-viral Drug NV-387 Could Stop Dormant Cancer Cells From Reawakening After Viral Infections - Stock Titan

Aug 18, 2025
pulisher
Aug 18, 2025

Is NanoViricides Inc. still worth holding after the dipJuly 2025 Reactions & Long-Term Growth Plans - Newser

Aug 18, 2025
pulisher
Aug 18, 2025

Is NanoViricides Inc. Stock a Smart Buy in 2025 Investment Analysis InsideTrade Entry Report & Long-Term Investment Growth Plans - Newser

Aug 18, 2025
pulisher
Aug 18, 2025

Intraday pattern recognizer results for NanoViricides Inc.Weekly Trend Report & Low Drawdown Momentum Ideas - Newser

Aug 18, 2025
pulisher
Aug 18, 2025

NanoViricides Inc. stock momentum explainedEntry Point & High Return Stock Watch Alerts - Newser

Aug 18, 2025
pulisher
Aug 17, 2025

How to integrate NanoViricides Inc. into portfolio analysis toolsQuarterly Portfolio Review & Free High Return Stock Watch Alerts - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

Will NanoViricides Inc. outperform the marketVolume Spike & Technical Confirmation Trade Alerts - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

Automated trading signals detected on NanoViricides Inc.2025 Volume Leaders & Expert Curated Trade Ideas - Newser

Aug 17, 2025
pulisher
Aug 16, 2025

Can NanoViricides Inc. maintain its current growth rateQuarterly Portfolio Review & Daily Profit Maximizing Tips - thegnnews.com

Aug 16, 2025
pulisher
Aug 16, 2025

Real time breakdown of NanoViricides Inc. stock performanceRate Cut & Safe Capital Growth Stock Tips - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

XTX Topco Ltd Takes Position in NanoViricides, Inc. (NYSE:NNVC) - Defense World

Aug 16, 2025

NanoViricides Inc Stock (NNVC) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$24.65
price up icon 0.94%
$85.04
price down icon 1.72%
$26.20
price up icon 0.73%
$110.88
price up icon 0.10%
$131.88
price down icon 0.54%
biotechnology ONC
$313.67
price down icon 0.10%
Cap:     |  Volume (24h):